Literature DB >> 13941389

Differentiation of two genetically specific types of depression by the response to anti-depressants.

C M PARE, L REES, M J SAINSBURY.   

Abstract

Entities:  

Keywords:  ANTIDEPRESSIVE AGENTS; IMIPRAMINE; IPRONIAZID; ISOCARBXAZID; MONOAMINE OXIDASE INHIBITORS; NIALAMIDE; TRIFLUOPERAZINE

Mesh：

Substances：

Year:  1962        PMID： 13941389     DOI： 10.1016/s0140-6736(62)91019-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

Review 1.  Genetics and psychopharmacology: prospects for individualized treatment.

Authors:  Charles U Nnadi; Joseph F Goldberg; Anil K Malhotra
Journal:  Essent Psychopharmacol       Date:  2005

Review 2.  Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.

Authors:  Chiara Fabbri; Alessandro Serretti
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

3.  CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD).

Authors:  Peng Wang; Yanjie Yang; Xiuxian Yang; Xiaohui Qiu; Zhengxue Qiao; Lin Wang; Xiongzhao Zhu; Hong Sui; Jingsong Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Monamine oxidase inhibitors and brain monamines in clinical conditions.

Authors:  C M Pare
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

5.  Letter: Atypical depressions.

Authors:  G M Taylor
Journal:  Can Med Assoc J       Date:  1974-10-05       Impact factor: 8.262

6.  Are monoamine-oxidase inhibitors antidepressants?

Authors:  T P Tyrer
Journal:  Proc R Soc Med       Date:  1973-09

Review 7.  Psychotropic drugs.

Authors:  J Hinton
Journal:  Postgrad Med J       Date:  1968-04       Impact factor: 2.401

8.  New horizons in psychopharmacology.

Authors:  W Linford
Journal:  Proc R Soc Med       Date:  1972-09

Review 9.  Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Authors:  Katarzyna Drozda; Daniel J Müller; Jeffrey R Bishop
Journal:  Pharmacotherapy       Date:  2014-02       Impact factor: 4.705

10.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.

Authors:  Firoza Mamdani; Marcelo T Berlim; Marie-Martine Beaulieu; Gustavo Turecki
Journal:  World J Biol Psychiatry       Date:  2013-03-26       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.